Quick answers
- What is Reclast?
- Reclast is a brand name of Zoledronic acid, a prescription medicine. The FDA NDC Directory lists 1 Reclast product in 1 strength and form.
- Who makes Reclast?
- Sandoz holds the FDA application for Reclast (NDA021817, approved April 16, 2007).
- Is there a generic or store brand of Reclast?
- Yes. The FDA NDC Directory lists 8 other products with the same active ingredients, strength and form as a Reclast product, 8 of them generic. Ask your pharmacist whether one is right for you.
- Has Reclast been recalled?
- No recall linked to Reclast products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Reclast is
Each Reclast product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Zoledronic acid · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| zoledronic acid 5 mg/100 mL injection, solution (intravenous) | Reclast | 8 products, 7 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Zoledronic acid →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021817 | Sandoz | April 16, 2007 | 1 |
Companies that list Reclast
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Reclast products.
- Sandoz Inc1 product
Recalls
No recall linked to Reclast products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.